Xinyun Zhang

San Xiang Road 1055
Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization.

Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization.

Journal: Pharmaceutics

Published: July 01, 2026

Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.

Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 13, 2026

Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment.

Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment.

Journal: Frontiers in cellular and infection microbiology

Published: January 29, 2026

Development and application of a simple LC-MS/MS method for therapeutic drug monitoring to guide colistin dosing in critically Ill patients.

Development and application of a simple LC-MS/MS method for therapeutic drug monitoring to guide colistin dosing in critically Ill patients.

Journal: BMC pharmacology & toxicology

Published: December 15, 2025

Comparison of the effects of rapamycin and AZD8055 on colon cancer cells through UPLC-MS/MS-based metabolomics.

Comparison of the effects of rapamycin and AZD8055 on colon cancer cells through UPLC-MS/MS-based metabolomics.

Journal: Journal of pharmaceutical and biomedical analysis

Published: September 03, 2025

DC-CD4 bispecific tolerogenic nanovesicles induce antigen-specific regulatory T cells and ameliorate collagen-induced arthritis in mice.

DC-CD4 bispecific tolerogenic nanovesicles induce antigen-specific regulatory T cells and ameliorate collagen-induced arthritis in mice.

Journal: Nature communications

Published: June 19, 2025

Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL.

Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL.

Journal: Molecular carcinogenesis

Published: January 02, 2025

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

Journal: Journal of nanobiotechnology

Published: December 20, 2024

Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.

Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.

Journal: Oncogenesis

Published: July 05, 2024

Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.

Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.

Journal: Blood advances

Published: December 19, 2023

Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis.

Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 22, 2023

A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.

A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.

Journal: Annals of hematology

Published: October 09, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026